Tenaya Therapeutics Statistics

Total Valuation

TNYA has a market cap or net worth of $365.11 million. The enterprise value is $254.22 million.

Market Cap	365.11M
Enterprise Value	254.22M

Important Dates

The last earnings date was Tuesday, May 14, 2024, after market close.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

TNYA has 78.52 million shares outstanding. The number of shares has increased by 10.79% in one year.

Shares Outstanding	78.52M
Shares Change (YoY)	+10.79%
Shares Change (QoQ)	+8.84%
Owned by Insiders (%)	1.12%
Owned by Institutions (%)	71.93%
Float	55.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.31
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.72, with a Debt / Equity ratio of 0.07.

Current Ratio	6.72
Quick Ratio	n/a
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -76.40% and return on invested capital (ROIC) is -77.40%.

Return on Equity (ROE)	-76.40%
Return on Assets (ROA)	-64.80%
Return on Capital (ROIC)	-77.40%
Revenue Per Employee	n/a
Profits Per Employee	-$889,821
Employee Count	140
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.83% in the last 52 weeks. The beta is 2.62, so TNYA's price volatility has been higher than the market average.

Beta (1Y)	2.62
52-Week Price Change	-34.83%
50-Day Moving Average	4.68
200-Day Moving Average	3.67
Relative Strength Index (RSI)	54.38
Average Volume (30 Days)	447,154

Short Selling Information

The latest short interest is 3.63 million, so 4.63% of the outstanding shares have been sold short.

Short Interest	3.63M
Short Previous Month	3.37M
Short % of Shares Out	4.63%
Short % of Float	6.52%
Short Ratio (days to cover)	12.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-131.23M
Pretax Income	-124.58M
Net Income	-124.58M
EBITDA	-112.68M
EBIT	-124.58M
Earnings Per Share (EPS)	-$1.64

Full Income Statement

Balance Sheet

The company has $122.25 million in cash and $11.37 million in debt, giving a net cash position of $110.88 million or $1.41 per share.

Cash & Cash Equivalents	122.25M
Total Debt	11.37M
Net Cash	110.88M
Net Cash Per Share	$1.41
Equity / Book Value	158.18M
Book Value Per Share	2.01
Working Capital	109.54M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$100.44 million and capital expenditures -$1.17 million, giving a free cash flow of -$101.62 million.

Operating Cash Flow	-100.44M
Capital Expenditures	-1.17M
Free Cash Flow	-101.62M
FCF Per Share	-$1.26

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TNYA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.79%
Shareholder Yield	-10.79%
Earnings Yield	-34.12%
FCF Yield	-27.83%

Analyst Forecast

The average price target for TNYA is $15.00, which is 221.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	221.89%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2